サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790313

エソテリック検査の市場規模、シェア、動向分析レポート：タイプ別、技術別、エンドユース別、地域別、セグメント別予測、2025年～2030年

Esoteric Testing Market Size, Share & Trends Analysis Report By Type (Oncology Testing, Infectious Disease Testing, Infectious Genetic Testing), By Technology, By End Use (Hospital-based Laboratories) By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
エソテリック検査の市場規模、シェア、動向分析レポート：タイプ別、技術別、エンドユース別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年07月03日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エソテリック検査市場のサマリー

世界のエソテリック検査市場規模は、2024年に246億米ドルと推計され、2025年から2030年にかけてCAGR 11.8%で成長し、2030年には479億8,000万米ドルに達すると予測されます。この市場成長の背景には、疾病の早期診断に対する需要の高まりと、より安全な診断オプションに対する需要を後押しするがんの有病率の上昇があります。

米国生物工学情報センター（NCBI）によると、2025年には米国で約204万1910人のがん患者が診断され、61万8120人が死亡すると予想されています。現在利用可能なエソテリック検査オプションの有利な成長可能性と、技術的に先進的で手頃な価格の検査に対する高い需要が、今後数年間の市場成長を促進すると予想される要因です。さらに、独立検査機関や基準検査機関における高度なエソテリック検査技術の採用は、エソテリック検査業界を牽引すると予想されます。

エソテリック検査は、個別化治療計画を策定するための特定の遺伝子マーカーやバイオマーカーの特定に極めて重要です。例えば、2023年2月、F. Hoffmann-La Roche Ltdは、コンパニオン診断に注力することで個別化ヘルスケアを推進するため、Janssenとの提携を延長し、研究とイノベーション活動をさらに強化すると発表しました。このように、世界的に個別化医療への嗜好が高まっていることから、今後数年間は製品需要が高まると予想されます。リアルタイムポリメラーゼ連鎖反応（PCR）、次世代シーケンシングなどの技術的進歩により、外科医や患者のエソテリック検査への志向が高まっていることが、高度診断薬需要増加の主要な促進要因になると予想されます。難解な診断の例としては、珍しい病気に対する遺伝子検査、珍しい感染症に対する特殊な検査、高度なバイオマーカーアッセイなどがあります。標準的な血液検査や尿検査とは対照的に、難解な診断は通常、必要な設備と人員を備えたリファレンスラボに委託されます。これらの検査は、その高い特異性と有効性により、特定の治療現場や科学的調査において有益です。

個別化治療への傾向の高まりにより、エソテリック検査のニーズが大幅に増加しています。各患者に特化した標的療法を特定するため、こうした特殊な検査では患者の遺伝子組成、タンパク質プロファイル、バイオマーカーを調べる。個別化医療や精密診断に対する意識の高まりに伴い、ターゲットを絞ったカスタマイズされた検査戦略の必要性が高まっています。診断検査の払い戻しなど、さまざまな施設を提供するための政府によるイニシアチブの増加も、市場を牽引すると予想される主な要因です。多くのヘルスケア機関が検査施設と協力して、さまざまなエソテリック検査を統合しています。

ここ数年、政府や民間の保険会社が提供する政策によって、これらの処置の適用範囲が拡大しています。したがって、支援的な償還政策や規制政策も市場の主要促進要因となっています。メディケアとメディケイドは様々なエソテリック検査に対する償還を増やしています。加えて、民間保険会社は患者に手頃な価格の検査を提供するために難分解性ラボと提携しており、これにより患者の自己負担額が減り、エソテリック検査へのアクセスが増加し、市場の成長を促進しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 エソテリック検査市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • エソテリック検査市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 エソテリック検査市場：タイプ推定・動向分析

  • タイプセグメントダッシュボード
  • エソテリック検査市場：タイプ変動分析
  • 世界のエソテリック検査市場規模と動向分析（タイプ別、2018～2030年）
  • 腫瘍学検査
  • 感染症検査
  • 遺伝子検査
  • 内分泌検査
  • 毒性試験
  • 神経学的検査
  • その他

第5章 エソテリック検査市場：技術推定・動向分析

  • テクノロジーセグメントダッシュボード
  • エソテリック検査市場：技術変動分析
  • 世界のエソテリック検査市場規模と動向分析（技術別、2018～2030年）
  • 化学発光免疫測定
  • 酵素免疫測定法
  • 質量分析
  • リアルタイムポリメラーゼ連鎖反応
  • フローサイトメトリー
  • その他

第6章 エソテリック検査市場：最終用途の推定・動向分析

  • タイプセグメントダッシュボード
  • エソテリック検査市場：最終用途変動分析
  • 世界の難解試験市場規模と動向分析（最終用途別、2018～2030年）
  • 病院併設の検査室
  • 独立系およびリファレンスラボ
  • その他

第7章 エソテリック検査市場：地域推定・動向分析

  • 地域市場ダッシュボード
  • 地域別市場シェア分析、2024年および2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ（MEA）
    • アルゼンチン
    • 南アフリカ
    • 南アラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • Key Company Heat Map Analysis, 2024
  • 企業プロファイル
    • Labcorp.
    • OPKO HEALTH, INC.
    • Quest Diagnostics Incorporated
    • Sonic Healthcare Limited
    • HU Group Holdings, Inc.
    • Kindstar Globalgene Technology, Inc.
    • Stanford Health Care
    • Mayo Foundation for Medical Education and Research
    • ARUP Laboratories
    • Athena Esoterix
    • ACM Global Laboratories
    • Healius Limited.
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Mexico esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Europe esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Germany esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 23 Germany esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Germany esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 26 France esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 27 France esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Italy esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Spain esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Denmark esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Sweden esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Sweden esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Norway esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 China esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 51 China esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 China esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 54 India esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 55 India esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 61 South Korea esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 63 Thailand esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Thailand esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 66 Latin America esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Latin America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Latin America esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Brazil esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 70 Brazil esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Brazil esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Arabia esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Arabia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Arabia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait esoteric testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Esoteric testing market: Market outlook
  • Fig. 10 Esoteric testing competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Esoteric testing market driver impact
  • Fig. 16 Esoteric testing market restraint impact
  • Fig. 17 Esoteric testing market strategic initiatives analysis
  • Fig. 18 Esoteric testing market: Type movement analysis
  • Fig. 19 Esoteric testing market: Type outlook and key takeaways
  • Fig. 20 Oncology testing market estimates and forecast, 2018 - 2030
  • Fig. 21 Infectious disease testing market estimates and forecast, 2018 - 2030
  • Fig. 22 Genetic testing market estimates and forecast, 2018 - 2030
  • Fig. 23 Endocrinology testing market estimates and forecast, 2018 - 2030
  • Fig. 24 Toxicology testing market estimates and forecast, 2018 - 2030
  • Fig. 25 Neurology testing market estimates and forecast, 2018 - 2030
  • Fig. 26 Other market estimates and forecast, 2018 - 2030
  • Fig. 27 Esoteric testing market: Technology movement analysis
  • Fig. 28 Esoteric testing market: Technology outlook and key takeaways
  • Fig. 29 Chemiluminescence immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 30 Enzyme-linked immunosorbent assay market estimates and forecasts,2018 - 2030
  • Fig. 31 Mass spectrometry market estimates and forecasts, 2018 - 2030
  • Fig. 32 Real time polymerase chain reaction market estimates and forecasts, 2018 - 2030
  • Fig. 33 Flow cytometry market estimates and forecasts, 2018 - 2030
  • Fig. 34 Other market estimates and forecasts, 2018 - 2030
  • Fig. 35 Esoteric testing market: End use movement analysis
  • Fig. 36 Esoteric testing market: End use outlook and key takeaways
  • Fig. 37 Hospital-based laboratories esoteric testing market estimates and forecast, 2018 - 2030
  • Fig. 38 Independent and reference laboratories esoteric testing estimates and forecast, 2018 - 2030
  • Fig. 39 Global esoteric testing market: Regional movement analysis
  • Fig. 40 Global esoteric testing market: Regional outlook and key takeaways
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 43 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 44 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 48 France market estimates and forecasts, 2018 - 2030
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 India market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 60 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 63 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 64 Middle East & Africa (MEA) market estimates and forecasts, 2018 - 2030
  • Fig. 65 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 67 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 68 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-4-68040-272-6

Esoteric Testing Market Summary

The global esoteric testing market size was estimated at USD 24.6 billion in 2024 and is projected to reach USD 47.98 billion by 2030, growing at a CAGR of 11.8% from 2025 to 2030. The market growth can be attributed to the increasing demand for early disease diagnosis and the rising prevalence of cancer, which impels the demand for safer diagnostic options.

According to the National Center for Biotechnology Information (NCBI), around 2,041,910 cancer cases will be diagnosed, with 618,120 cancer deaths expected in the U.S. in 2025. The lucrative growth potential of currently available esoteric testing options and high demand for technologically advanced and affordable tests are the factors expected to drive the market growth in the coming years. Moreover, the adoption of advanced esoteric testing technologies in independent and reference laboratories is anticipated to drive the esoteric testing industry.

Esoteric tests are crucial in identifying particular genetic markers and biomarkers to develop personalized treatment plans. For instance, in February 2023, F. Hoffmann-La Roche Ltd announced the extension of its collaboration with Janssen to advance personalized healthcare by focusing on companion diagnostics, further strengthening research and innovation activities. Thus, the rising preference for personalized medicine worldwide is anticipated to boost product demand in the coming years. The growing inclination of surgeons and patients for esoteric tests due to technological advancements, such as real-time Polymerase Chain Reaction (PCR), next-generation sequencing, and others, is anticipated to be a key driver of the rising demand for advanced diagnostics. Examples of esoteric diagnostics are genetic tests for uncommon illnesses, specialized tests for unusual infections, and advanced biomarker assays. In contrast to standard blood or urine testing, esoteric diagnostics are usually outsourced to reference labs equipped with the necessary equipment and personnel. These tests can be beneficial in specific therapeutic settings or scientific investigations owing to their high specificity and effectiveness, even though the demand is usually low due to the high cost.

The growing trend toward personalized treatment has led to a significant increase in the need for esoteric tests. To identify targeted therapies specific to each patient, these specialized tests examine a patient's genetic composition, protein profiles, and biomarkers. With the growing adoption of personalized medicine and precision diagnostics due to increased awareness, targeted and customized testing strategies are becoming increasingly necessary. An increase in initiatives undertaken by the government to provide various facilities, such as reimbursement for diagnostic tests, is another major factor anticipated to drive the market. Many healthcare institutions are working with laboratories to integrate different esoteric tests.

Over the last few years, the coverage for these procedures by policies offered by government and private insurance providers has increased. Hence, supportive reimbursement and regulatory policies also act as key drivers of the market. Medicare and Medicaid have increased reimbursement for various esoteric tests. In addition, private insurers are collaborating with esoteric labs to offer patients affordable tests, which lower out-of-pocket costs for patients and increase access to esoteric tests, thereby driving market growth.

Esoteric Testing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels as well as provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the esoteric testing market report on the basis of product, technology, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology testing
  • Infectious disease testing
  • Genetic testing
  • Endocrinology testing
  • Toxicology testing
  • Neurology testing
  • Others
  • Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemiluminescence immunoassay
  • Enzyme-linked immunosorbent assay
  • Mass spectrometry
  • Real time polymerase chain reaction
  • Flow cytometry
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital-based laboratories
  • Independent and reference laboratories
  • Other
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Technology
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Technology Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Esoteric Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Esoteric Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Esoteric Testing Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Esoteric Testing Market: Type Movement Analysis
  • 4.3. Global Esoteric Testing Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
  • 4.4. Oncology Testing
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Infectious Disease Testing
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Genetic Testing
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.7. Endocrinology Testing
    • 4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.8. Toxicology Testing
    • 4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.9. Neurology Testing
    • 4.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Esoteric Testing Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Esoteric Testing Market: Technology Movement Analysis
  • 5.3. Global Esoteric Testing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. Chemiluminescence Immunoassay
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Enzyme-linked Immunosorbent Assay
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Mass Spectrometry
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Real Time Polymerase Chain Reaction
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Flow Cytometry
    • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Esoteric Testing Market: End Use Estimates & Trend Analysis

  • 6.1. Type Segment Dashboard
  • 6.2. Esoteric Testing Market: End Use Movement Analysis
  • 6.3. Global Esoteric Testing Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital-based Laboratories
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Independent and Reference Laboratories
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Other
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Esoteric Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Continuous Bioprocessing Market By Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. South Korea
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa (MEA)
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Middle East & Africa (MEA)Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. South Africa
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. South Arabia
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.5. UAE
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.5.3. Competitive Scenario
      • 7.8.5.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.6. Kuwait
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Regulatory Framework/Reimbursement Structure
      • 7.8.6.3. Competitive Scenario
      • 7.8.6.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Labcorp.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Type Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. OPKO HEALTH, INC.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Type Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Quest Diagnostics Incorporated
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Type Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Sonic Healthcare Limited
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Type Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. H.U. Group Holdings, Inc.
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Type Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Kindstar Globalgene Technology, Inc.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Type Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Stanford Health Care
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Type Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Mayo Foundation for Medical Education and Research
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Type Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. ARUP Laboratories
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Type Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Athena Esoterix
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Type Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. ACM Global Laboratories
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Type Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. Healius Limited.
      • 8.4.12.1. Company Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Type Benchmarking
      • 8.4.12.4. Strategic Initiatives